scholarly article | Q13442814 |
P356 | DOI | 10.1016/0092-8674(95)90470-0 |
P953 | full work available at URL | https://doi.org/10.1016/0092-8674(95)90470-0 |
https://api.elsevier.com/content/article/PII:0092867495904700?httpAccept=text/xml | ||
https://api.elsevier.com/content/article/PII:0092867495904700?httpAccept=text/plain | ||
P3181 | OpenCitations bibliographic resource ID | 2768500 |
P698 | PubMed publication ID | 7671302 |
P2093 | author name string | N. A. Jenkins | |
N. G. Copeland | |||
C. I. Brannan | |||
K. S. Vogel | |||
L. F. Parada | |||
P2860 | cites work | The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells, and oligodendrocytes | Q24309158 |
The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins | Q24324729 | ||
The GTPase superfamily: conserved structure and molecular mechanism | Q27860524 | ||
Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues | Q28238680 | ||
Proteins regulating Ras and its relatives | Q28257295 | ||
Development of the rat superior cervical ganglion: ganglion cell maturation | Q28286388 | ||
The neurofibromatosis type 1 gene encodes a protein related to GAP | Q28301160 | ||
WT-1 is required for early kidney development | Q28512266 | ||
Tumour predisposition in mice heterozygous for a targeted mutation in Nf1 | Q28594951 | ||
The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21 | Q28609120 | ||
The trk Proto-Oncogene Product: a Signal Transducing Receptor for Nerve Growth Factor | Q28609789 | ||
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours | Q29547697 | ||
Effects of an Rb mutation in the mouse | Q29619196 | ||
Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis | Q29619200 | ||
The Son of sevenless Gene Product: a Putative Activator of Ras | Q33278914 | ||
Tyrosine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product induced by NGF. | Q34576586 | ||
Neurofibromin can inhibit Ras-dependent growth by a mechanism independent of its GTPase-accelerating function | Q36644173 | ||
A branched signaling pathway for nerve growth factor is revealed by Src-, Ras-, and Raf-mediated gene inductions | Q36684518 | ||
Cell death during development of the nervous system | Q37716922 | ||
The Migration and Differentiation of Neural Crest Cells | Q39987720 | ||
Neurotrophin signal transduction by the Trk receptor | Q40590914 | ||
Function and regulation of ras. | Q40835314 | ||
The neurofibromatosis type 1 gene and its protein product, neurofibromin. | Q40890889 | ||
NT-3 stimulates sympathetic neuroblast proliferation by promoting precursor survival | Q41512784 | ||
Benzodiazepine peptidomimetics: potent inhibitors of Ras farnesylation in animal cells | Q41546925 | ||
Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor | Q41546932 | ||
Sequence homology shared by neurofibromatosis type-1 gene and IRA-1 and IRA-2 negative regulators of the RAS cyclic AMP pathway. | Q41909163 | ||
Neuroblast mitosis in dissociated culture: regulation and relationship to differentiation | Q42110280 | ||
Involvement of ras p21 in neurotrophin-induced response of sensory, but not sympathetic neurons | Q42181592 | ||
ras p21 protein promotes survival and fiber outgrowth of cultured embryonic neurons | Q43456719 | ||
Neurotrophins regulate sequential changes in neurotrophin receptor expression by sympathetic neuroblasts | Q43473220 | ||
Nerve growth factor stimulation of the Ras-guanine nucleotide exchange factor and GAP activities | Q43502690 | ||
The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae | Q43515231 | ||
The duration of neurotrophic factor independence in early sensory neurons is matched to the time course of target field innervation | Q43688695 | ||
Requirement for a functional Rb-1 gene in murine development | Q44462954 | ||
Neurofibromatosis: past, present, and future | Q45012916 | ||
Ras1 and a putative guanine nucleotide exchange factor perform crucial steps in signaling by the sevenless protein tyrosine kinase. | Q46027909 | ||
Neuronal precursor cells in chick dorsal root ganglia: differentiation and survival in vitro | Q48097872 | ||
C. elegans lin-45 raf gene participates in let-60 ras-stimulated vulval differentiation. | Q48120347 | ||
Neurofibromin, a predominantly neuronal GTPase activating protein in the adult, is ubiquitously expressed during development | Q48417018 | ||
Differential expression and tissue distribution of type I and type II neurofibromins during mouse fetal development. | Q52218417 | ||
Neurotrophin-4/5 is a mammalian-specific survival factor for distinct populations of sensory neurons. | Q52222083 | ||
Relation of target encounter and neuronal death to nerve growth factor responsiveness in the developing mouse trigeminal ganglion. | Q52276034 | ||
Caenorhabditis elegans ras gene let-60 acts as a switch in the pathway of vulval induction | Q59067261 | ||
Timing and site of nerve growth factor synthesis in developing skin in relation to innervation and expression of the receptor | Q59085748 | ||
Development of mouse dorsal root ganglia: an autoradiographic and quantitative study | Q66944111 | ||
Tumor suppressor genes | Q68264184 | ||
Contributions of placodal and neural crest cells to avian cranial peripheral ganglia | Q71755691 | ||
Cooperative tumorigenic effects of germline mutations in Rb and p53 | Q72781894 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Neurofibromin 1 | Q21987763 |
P304 | page(s) | 733–742 | |
P577 | publication date | 1995-09-08 | |
P1433 | published in | Cell | Q655814 |
P1476 | title | Loss of neurofibromin results in neurotrophin-independent survival of embryonic sensory and sympathetic neurons | |
P478 | volume | 82 |
Q40114274 | A mouse embryonic stem cell model of Schwann cell differentiation for studies of the role of neurofibromatosis type 1 in Schwann cell development and tumor formation |
Q28590440 | A mouse model for the learning and memory deficits associated with neurofibromatosis type I |
Q35538007 | A novel cytokine pathway suppresses glial cell melanogenesis after injury to adult nerve. |
Q37010210 | A sympathetic neuron autonomous role for Egr3-mediated gene regulation in dendrite morphogenesis and target tissue innervation |
Q28591548 | Aberrant growth and differentiation of oligodendrocyte progenitors in neurofibromatosis type 1 mutants |
Q28506943 | Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain |
Q48579817 | Absence of sensory neurons before target innervation in brain-derived neurotrophic factor-, neurotrophin 3-, and TrkC-deficient embryonic mice. |
Q40669421 | Activation of Ras is necessary and sufficient for upregulation of vanilloid receptor type 1 in sensory neurons by neurotrophic factors |
Q40079265 | An orthotopic xenograft model of intraneural NF1 MPNST suggests a potential association between steroid hormones and tumor cell proliferation. |
Q34982037 | Antiangiogenesis in neurofibromatosis 1. |
Q48553777 | BDNF activated TrkB/IRR receptor chimera promotes survival of sympathetic neurons through Ras and PI-3 kinase signaling |
Q41098501 | Ca(2+)-dependent routes to Ras: mechanisms for neuronal survival, differentiation, and plasticity? |
Q37957006 | Cancer and altered metabolism: potential importance of hypoxia-inducible factor and 2-oxoglutarate-dependent dioxygenases |
Q41127708 | Characterization of a CNS cell line, CAD, in which morphological differentiation is initiated by serum deprivation. |
Q38857220 | Contextual signaling in cancer |
Q73134830 | Crystallization and preliminary X-ray crystallographic study of the Ras-GTPase-activating domain of human p120GAP |
Q33831164 | Defective cAMP generation underlies the sensitivity of CNS neurons to neurofibromatosis-1 heterozygosity |
Q43891495 | Defective proliferative responses in B lymphocytes and thymocytes that lack neurofibromin. |
Q51993829 | Deletion of Nf1 in neurons induces increased axon collateral branching after dorsal root injury. |
Q43775812 | Differential localization of the neurofibromatosis 1 (NF1) gene product, neurofibromin, with the F-actin or microtubule cytoskeleton during differentiation of telencephalic neurons |
Q53424114 | Early-onset epileptic encephalopathy and severe developmental delay in an association with de novo double mutations in NF1 and MAGEL2. |
Q28071845 | Effect of Estradiol on Neurotrophin Receptors in Basal Forebrain Cholinergic Neurons: Relevance for Alzheimer's Disease |
Q35686940 | Genetically engineered mouse models shed new light on the pathogenesis of neurofibromatosis type I-related neoplasms of the peripheral nervous system |
Q73381855 | Homozygous deletion of the neurofibromatosis-1 gene in the tumor of a patient with neuroblastoma |
Q46940429 | Hyperactivation of protein kinase B and ERK have discrete effects on survival, proliferation, and cytokine expression in Nf1-deficient myeloid cells |
Q24649500 | Identification of neurofibromin mutants that exhibit allele specificity or increased Ras affinity resulting in suppression of activated ras alleles |
Q28077909 | Intrinsic Axonal Growth and the Drive for Regeneration |
Q46486969 | Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells |
Q41099828 | Mechanisms of carcinogenesis and the mutant mouse |
Q37391841 | Mice lacking neurofibromin develop gastric hyperplasia |
Q33842573 | Molecular and cellular mechanisms of cognitive function: implications for psychiatric disorders |
Q37719525 | Molecular and cellular mechanisms of learning disabilities: a focus on NF1. |
Q33649025 | Molecular markers of paragangliomas/pheochromocytomas |
Q24682869 | Mouse models of neurofibromatosis 1 and 2. |
Q74825193 | Murine tumor suppressor models |
Q28203741 | NF1 tumor suppressor gene function: narrowing the GAP |
Q52177288 | Nerve growth factor induces survival and differentiation through two distinct signaling cascades in PC12 cells. |
Q34020118 | Neurofibromatosis type 1. |
Q34330612 | Neurofibromatosis type 1: II. Answers from animal models |
Q34305314 | Neurofibromatosis type 1: modeling CNS dysfunction |
Q28279834 | Neurofibromatosis type 1: piecing the puzzle together |
Q35613659 | Neurofibromatosis-1 heterozygosity impairs CNS neuronal morphology in a cAMP/PKA/ROCK-dependent manner |
Q92618072 | Neurofibromin 1 expression is negatively correlated with malignancy and prognosis of epithelial ovarian cancer |
Q34982048 | Neurofibromin in the brain |
Q37383613 | Neurofibromin is required for barrel formation in the mouse somatosensory cortex |
Q42141084 | Neurofibromin modulates adult hippocampal neurogenesis and behavioral effects of antidepressants |
Q24673115 | Neurology and the skin |
Q37582476 | Neuronal apoptosis by prolyl hydroxylation: implication in nervous system tumours and the Warburg conundrum |
Q28267037 | Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer |
Q34411046 | Neuronal survival depends on EGFR signaling in cortical but not midbrain astrocytes |
Q27876223 | Neurotrophin signal transduction in the nervous system |
Q36096852 | Neurotrophin-dependent dendritic filopodial motility: a convergence on PI3K signaling |
Q36366410 | Nf1 mutation expands an EGFR-dependent peripheral nerve progenitor that confers neurofibroma tumorigenic potential. |
Q28588037 | Nf1-deficient mouse Schwann cells are angiogenic and invasive and can be induced to hyperproliferate: reversion of some phenotypes by an inhibitor of farnesyl protein transferase |
Q50655894 | Oligodendrocyte Nf1 Controls Aberrant Notch Activation and Regulates Myelin Structure and Behavior. |
Q77752534 | Parallels between tuberous sclerosis complex and neurofibromatosis 1: common threads in the same tapestry |
Q52035629 | Points of convergence between Ca2+ and Ras signalling pathways. |
Q57042606 | Ras regulates sympathetic neuron survival by suppressing the p53-mediated cell death pathway |
Q36678858 | Recent insights into the molecular pathogenesis of pheochromocytoma and paraganglioma |
Q30486851 | Reduced expression of neurofibromin in human meningiomas |
Q41135422 | Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: the potential for multiplex signalling |
Q28679078 | Signalling for survival and death in neurones: the role of stress-activated kinases, JNK and p38 |
Q71143832 | Structural differences in the minimal catalytic domains of the GTPase-activating proteins p120GAP and neurofibromin |
Q41875026 | Sustained activation of p42/p44 mitogen-activated protein kinase during recovery from simulated ischaemia mediates adaptive cytoprotection in cardiomyocytes |
Q28572990 | The BRN-3A transcription factor protects sensory but not sympathetic neurons from programmed cell death/apoptosis |
Q28590121 | The Nf1 tumor suppressor regulates mouse skin wound healing, fibroblast proliferation, and collagen deposited by fibroblasts |
Q40821493 | The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells. |
Q36557701 | The cyclin-dependent kinase inhibitor p21 (WAF1) is required for survival of differentiating neuroblastoma cells |
Q36935323 | The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells |
Q34770308 | The molecular and genetic basis of neurological tumours |
Q28204716 | The role of Kit-ligand in melanocyte development and epidermal homeostasis |
Q36253857 | The von Hippel-Lindau protein, HIF hydroxylation, and oxygen sensing |
Q34569380 | The von Hippel-Lindau tumor suppressor protein: roles in cancer and oxygen sensing |
Q37299263 | The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer |
Q36999097 | The von hippel-lindau tumor suppressor protein: an update |
Q42124538 | Transgenic activation of Ras in neurons promotes hypertrophy and protects from lesion-induced degeneration |
Q46655839 | TrkB dependent adult hippocampal progenitor differentiation mediates sustained ketamine antidepressant response. |
Q51971299 | Von Hippel-Lindau disease. |
Q28587133 | p21 ras and phosphatidylinositol-3 kinase are required for survival of wild-type and NF1 mutant sensory neurons |
Search more.